Myristoyl coenzyme A

CAS : 3130-72-1

Ref. 3D-NM47200

Informations sur le produit

• Nom: Myristoyl coenzyme A
• Synonymes: n-Tetradecanoyl coenzyme A, Coenzyme A, S-myristate, Coenzyme A, S-tetradecanoate, Coenzyme A, tetradecanoyl-, Myristoyl-coa, Myristoyl-coenzyme A, Myristyl coenzyme A, Myristyl-CoA, S-Tetradecanoyl-coenzyme A, S-{1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} tetradecanethioate (non-preferred name), Tetradecanethioic acid, S-ester with coenzyme A, Tetradecanoyl coenzyme A, Tetradecanoyl-coa, n-Tetradecanoyl-CoA

Description

Myristoyl coenzyme A is a potential drug that inhibits the binding of human pathogens to protein. It also has been shown to have potential as an inhibitor for reactions involving myristoylation, which is a process where proteins are modified with myristic acid. Myristoyl coenzyme A was synthesized using titration calorimetry and in vitro assays. The compound has been shown to have the ability to inhibit polymerase chain reaction (PCR) and reduce the growth of bacteria in vitro. Myristoyl coenzyme A may be useful in treating metabolic disorders and infectious diseases such as AIDS, tuberculosis, and malaria.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 995.91 g/mol
• Formule: C₃₅H₆₂N₇O₁₇P₃S·H₂O
• Degré de pureté: Min. 90%
• Couleur/Forme: White Powder